Latest Breaking News On - Centrexion therapeutics corp - Page 1 : comparemela.com
GB Sciences Featured & Speaking at the SACHS Associates 4th Annual Neuroscience Innovation Forum
LAS VEGAS, NV / ACCESSWIRE / April 27, 2021 / GB Sciences (GBS), Inc. (OTCQB:GBLX), a leading phytomedicine research and biopharmaceutical development company, will be featured during the SPOTLIGHT SHOWCASE at the SACHS Associates 4th Annual Neuroscience Innovation Forum (NIF) for Business Development, Licensing & Investment from April 28 to April 30. The SACHS NIF, which is entirely virtual, will include a SPOTLIGHT SHOWCASE session describing GB Sciences recent pivot and novel drug development pipeline. In addition, Dr. Andrea Small-Howard, the Chief Science Officer and Director of GB Sciences, is an invited speaker on the Pain, Migraines, and Addiction Panel during a live session on Therapeutics Day 2, April 29 at 11:50 a.m. EDT.
CanadaCanadianMark-demitrackNorbert-riedelSeth-ledermanRandall-stevensLas-vegasPradeep-banerjeeNeuroscience-innovation-forum-for-business-developmentNeuroscience-innovation-forumTrevena-incContract-research-organizations